Abstract: Equine parvovirus-hepatitis (EqPV-H) was first reported from the serum and liver tissue of a horse diagnosed with Theiler's disease in the United States in 2018. Theiler's disease, also known as equine serum hepatitis, is a severe hepatitis with fulminant hepatic necrosis. The disease has most frequently been reported following the administration of equine-origin biological products; however, it has also been reported in in-contact horses with no prior biologic administration. EqPV-H has been detected in clinically healthy horses in North America (USA, Canada), Europe (Germany, Austria, Slovenia), Asia (China, South Korea), and South America (Brazil). Previous prevalence studies conducted worldwide have shown the presence of EqPV-H DNA in serum or plasma ranging from 3.2 to 19.8%. This study investigated the prevalence of EqPV-H DNA in 170 healthy broodmares of various breeds located on 37 farms in southern Ontario, Canada. The occurrence of EqPV-H infection was determined by quantitative PCR for EqPV-H DNA in serum samples. The effects of age, breed, season, pregnancy status, and equine herpesvirus-1 (EHV-1) vaccination history on EqPV-H status were also investigated. There was a prevalence of 15.9% (27/170) with viral loads of EqPV-H ranging from detectable to 2900 copies/mL. Statistical analysis showed that increasing age was a significant factor in the detection of EqPV-H DNA. Neither breed, season, pregnancy status, nor EHV-1 vaccination history was significant in predicting EqPV-H infection status. L’hépatite à parvovirus équin (EqPV-H) a été signalée pour la première fois à partir du sérum et du tissu hépatique d’un cheval diagnostiqué avec la maladie de Theiler aux États-Unis en 2018. La maladie de Theiler, également connue sous le nom d’hépatite sérique équine, est une hépatite sévère avec nécrose hépatique fulminante. La maladie a été le plus souvent rapportée à la suite de l’administration de produits biologiques d’origine équine; cependant, il a également été signalé chez des chevaux en contact sans administration préalable de produit biologique. EqPV-H a été détecté chez des chevaux cliniquement sains en Amérique du Nord (États-Unis, Canada), en Europe (Allemagne, Autriche, Slovénie), en Asie (Chine, Corée du Sud) et en Amérique du Sud (Brésil). Des études de prévalence antérieures menées dans le monde entier ont montré la présence d’ADN EqPV-H dans le sérum ou le plasma allant de 3,2 à 19,8 %. Cette étude a examiné la prévalence de l’ADN EqPV-H chez 170 poulinières en bonne santé de différentes races situées dans 37 fermes du sud de l’Ontario, au Canada. La survenue d’une infection par EqPV-H a été déterminée par PCR quantitative pour l’ADN d’EqPV-H dans des échantillons de sérum. Les effets de l’âge, de la race, de la saison, de l’état de grossesse et des antécédents de vaccination contre l’herpèsvirus équin-1 (EHV-1) sur le statut EqPV-H ont également été étudiés. Il y avait une prévalence de 15,9 % (27/170) avec des charges virales d’EqPV-H allant de détectable à 2900 copies/mL. L’analyse statistique a montré que l’augmentation de l’âge était un facteur significatif dans la détection de l’ADN EqPV-H. Ni la race, ni la saison, ni l’état de grossesse, ni les antécédents de vaccination contre l’EHV-1 n’étaient significatifs pour prédire l’état de l’infection par l’EqPV-H.(Traduit par Docteur Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research focuses on the detection and prevalence of Equine Parvovirus-Hepatitis (EqPV-H) among healthy broodmares in southern Ontario, Canada. The virus was found in 15.9% of tested mares, with older horses showing a higher likelihood of infection.
Study Overview
The study was conducted to ascertain the prevalence of EqPV-H – a virus first identified in North America in 2018 and associated with a severe form of hepatitis known as Theiler’s disease – in healthy broodmares across 37 farms in southern Ontario, Canada.
Theiler’s disease typically occurs after horses are exposed to equine-origin biological products, though it has also been reported in horses that have not been administered such products.
The disease has global prevalence, with EqPV-H detected in healthy horses from Europe, Asia, and South America.
Previous research has indicated that EqPV-H DNA presence in horse serum or plasma can vary from 3.2% to 19.8%.
Methodology and Findings
The researchers collected serum samples from 170 healthy broodmares of varied breeds.
These samples underwent quantitative PCR testing for the presence of EqPV-H DNA, a method for determining the occurrence of the disease.
The horses’ age, breed, season, pregnancy status, and history of equine herpesvirus-1 (EHV-1) vaccination were also factored in to assess their impact on EqPV-H status.
Among the tested broodmares, 15.9% (27 out of 170) showed detectable to 2900 copies/mL viral loads of EqPV-H, indicating a presence of the virus.
Based on statistical analysis, the research determined that increasing age significantly impacted the detection of EqPV-H DNA in the horses. No other factors – breed, season, pregnancy status or EHV-1 vaccination history – showed a significant correlation to EqPV-H infection.
Conclusion
These findings indicate that EqPV-H is present in approximately 16% of the tested healthy broodmares in southern Ontario, Canada.
Greater susceptibility to the virus was noted in older horses, suggesting age as a risk factor for EqPV-H infection.
Cite This Article
APA
Papapetrou MA, Arroyo LG, Meister TL, Baird JD, Steinmann E, Lillie BN.
(2023).
Prevalence of equine parvovirus-hepatitis in healthy broodmares in Ontario, Canada.
Can J Vet Res, 87(3), 169-175.
https://doi.org/10.25318/3210037301-eng
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Arroyo, Luis G
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Meister, Toni L
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Baird, John D
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Steinmann, Eike
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Lillie, Brandon N
Department of Pathobiology (Papapetrou, Lillie) and Department of Clinical Studies (Arroyo, Baird) Ontario Veterinary College, University of Guelph, Ontario, Canada; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr-University Bochum, 44801 Bochum, Germany (Meister, Steinmann).
Tennant B, Baldwin B, Evans CD, Kaneko JJ. Diseases of the equine liver.. Proceedings of the 21st Annual Convention of American Association of Equine Practitioners December 1–3, 1975; Boston, Massachusetts. 1975. pp. 410–426.
Tennant B. Acute hepatitis in horses: Problems of differentiating toxic and infectious causes in the adult.. Proceedings of the 24th Annual Convention of American Association of Equine Practitioners December 2–6, 1978; St Louis, Missouri. 1978. pp. 465–471.
Theiler A. Acute liver-atrophy and parenchymatous hepatitis in horses. The Fifth and Sixth Reports of the Director of Veterinary Research, Department of Agriculture, Union of South Africa Pretoria South Africa: Government Printing and Stationery Office; 1918. pp. 7–164.
Tomlinson JE, Kapoor A, Kumar A, Tennant BC, Laverack MA, Beard L, Delph K, Davis E, Schott Ii H, Lascola K, Holbrook TC, Johnson P, Taylor SD, McKenzie E, Carter-Arnold J, Setlakwe E, Fultz L, Brakenhoff J, Ruby R, Trivedi S, Van de Walle GR, Renshaw RW, Dubovi EJ, Divers TJ. Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018).. J Vet Intern Med 2019 Jan;33(1):251-257.
Pénzes JJ, Söderlund-Venermo M, Canuti M, Eis-Hübinger AM, Hughes J, Cotmore SF, Harrach B. Reorganizing the family Parvoviridae: a revised taxonomy independent of the canonical approach based on host association.. Arch Virol 2020 Sep;165(9):2133-2146.
Jager MC, Tomlinson JE, Lopez-Astacio RA, Parrish CR, Van de Walle GR. Small but mighty: old and new parvoviruses of veterinary significance.. Virol J 2021 Oct 24;18(1):210.
Fortier C, El-Hage C, Hue E. Hepatitis viruses: Prevalence of equine parvovirus-hepatitis virus and equine hepacivirus in France and Australia. Equine Vet J 2021;53:68.